Ozempic is famous as a blood sugar control tool for type 2 diabetes, enhancing both fasting and postprandial glucose
American Journal of Obstetrics and Gynecology, 220 (1), B2B18
By reducing body weight, improving insulin sensitivity, lowering inflammatory markers, and addressing metabolic dysfunction, they target the very factors that make Hashimoto's management so challenging
In trials, it is a triple agonist it acts on three hormone pathways (GLP-1, GIP, and glucagon), one more than tirzepatide and two more than semaglutide
Clinical studies show that stopping the medication often leads to weight regain
The sum of all AAs was strongly positively correlated with glucose in the fasting state ( r = 0.78, P = 0.001) and at 30 minutes ( r = 0.59, P = 0.033)